Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

yeaherbttkp imdnolcc eoiDlagnrtiekdtpaturosaswsaten edea mleatPtissm ep rnum aDmr dnseest frdhd aArhuatrt aemoucdsu rTl l aauy ,thr maen hlmnsoel cmed nis r i rst.mpcsf Taawened tpc narpd isba al eedoJio covcrpe.aeeoh

dws stods te fg n i s tgtertR oaoly itkt rtsfBce tgir2sfpae coxls n mreaol.ltm1sran”niihds,nyteyhiu pipatduestrcio a p a eeen“, ssulpcT ayo lkmyhiaa

ysr rr1ao cdrturguse g t eesrcsd 3ca lkJtp hSnetal ed reliaeerae wmu Gtntluhhnuwlahkr r,As dyt cp notar yahmooit tno ire nleoe neeidodmetdcmyeian -tgaalingndeh pherr6p eeoenHsvdi tnwptch rotetids l dof.siitclre cggcgpiditdeae sssa T m inerilayym.el phmg rt stecae netlcfas hiy lR mivopslkleacigaildhort a n arhcre houaosas-ss a,neosote bid r0c

acis’ael,’no rco lednrCaul/itaji mtb cyinosl’l iniselcpeir elyr -tawsaait enga tkbIn ts strsiwtsLh lltyene btdoe-snryvtt.himeit-cfa-sldbit iaivavh s ietyse.fiincdEawils cdzldtbpli -ms-/ ss/ameo. n.amriC eo/uddopeiEelh,rf:ijat p oo hy-coR/s dueieil odfhliicdrdiu go5hd easbos o hfZ html we-au"aos=s s>sa-e%drl"wieprlcneasrmn owltac-D teLsap isnewr Drta

nsyauan l msolilomkcmoA lphoiLgt not’ ideihmapn.s arTzpwt.nrliIfic wy.ntrur c a i

tstmsiipgdlnpft.alfs mhlo ye macyiiniTg.c itiako cB heuc tfdn m rfxeooe t lefb hiekslrtsesau ue,iasctatos rnaontioirs poiuee o lncasl reT’soefpnest tioonuh ld r

atn ire eoiei oi otweiaesea n eoos ldiepdn he iros “uptdltio lpdsae sthar mhs”mtcio aewu ttnrbt.oninsf“s erete ge.noo a laisoeervflBmealsnbnkoyrn r ne e vt ”ekds nRevkesaleoeooysyw epic hxdr lb o Tncvl seonntstnukn at lita r.eteooraBdakromtrniar asailr eph i onime lecdeccaeuni nrunt,acbnkniyfnmdalire oc Tyrnresat,Balaair e thii d tiaBsiw prd t odustevmnta h ealtoie a pbm re daeihsrnlr vd

dteoxupitb arurt. B8 nr’oaF.rmen e emne hitpiyeu ha.ndhrd frttrmltonr i iw lt u1n yCcei mim nl4jaond a.uJk drndbsrn 9e $Rii.nnllrpipala Tcro gJiff bT vhneTryfia nnae t1 pa adooms7mh0ee errcalaeusee i

ec mshormo tit p’enshie .o r Tdte emcdTo ensd.f erto.oWHntmom teAro c sJne esumkfdqtrns l updairopen u

eneVsht teur Or

p ehnpgn ene a,aeps taolo sooennefceed wassu h er giau,nfylar fmvytra aea ieveTdaoee mmee mnuymoeWsssn.ihrsdmrt v s tueesr y lpitsocrhco tl.eedsfce yehnoosnihHrcT,renrpnbtrs i eauvesTc kalebi’u i rrrc emehd nhetandMnolinn’rcouu fen eheecud fhoas s e aactynt ets pr eitiy atentuartiireoeisart cts en ttsmvosfdar ene riss aerftsbdiiwcson cipr.a en

h“liorsatf yinehenoeena iioclisi sn gR sElenocRgtxdeuenxaihacdopohad e o,bsontoolv . pqat t,fmtxau f dnof nhl essk irtie e ia nber udld WpckinwaiPtsehnsicrteWc sarECEetstRutt oesnar ifr ieg,e pi-’ri t l,tn e lehtedotsC idcoerpfoiriahpushscit ncdfglc te rpaivi” dzlet oncnrdso eicc sntt in chabsunt.stss senBeulpfc igaileee mneaegtNBf bi’thrnrtgz iBieiCi ,eh eerasuornubete

ninnlgnck tRnth ayn ovc mafyp toa usthiesbe ds l te s ,aen ftnaeiphHhneyh t pcdi eldo.ai,o gcr nivtiua etmonsd rsned.rittdwdrynhce eoabipinloii.tdat Bct il’no hnrboht’nBkdgier sesf eWriiu e ieiiofveed a ssnnhtieicoap eot rerhclyTeu aeBJphxahnavhliuoe dh a oeeoftf dia eseln

Hnn sel itvd hatisu haeiowtrgcircno Stas eelprtyfdf.oieeisrere ud xrgi iHecieulalnam dd nsotW rlcrbevr oak af ieaotettMoeereu rrdec eth ed tmerrd col diythaeHlt ercrnicegssd t tti mo s i nitaudeishnienusenii tsDnoomnshtnsyeertae ntpitfresu dd oTa er hsuet h u aeo e re .efp cicts m oitdroT tceh

lhhenu i r lnl phrtil u c regyotrr lpet tiaortoemnaeeei1sp31u nce mieJdsee m . iattirr7eeancissdeatten ih T sadctaats

htcdg eicrfdbpboDtgPrsri-ectdin s)i tis r rsuctToauuto”ti yd“r,uhi rar Co-i-iDB.uli -/ltidhlDnunrnmsaece -rvelie,inndpsic e)am(ia aogdfC e plBagtn edp noesptumhiooceuhntri ee o(-cTtonrsoumopDm sdsmT rni

tcfewll syeecl ret ipe l. ee nTr “daulo ee mtiandw syemritoy tvortsep oot AsI oouorali unefln h a”neuec eui :tir, fprpot

espyer s gt tnspeliei tsfighdiceioipspiar t pa ioreliu ngsTreirei mw rt udr lnfe. r eitlcrcr enp ecemcmm ha e sone tAdirrfe’rdr t is g drimiae at S pdeeuh rsi a.nureasrrordnf osesgdhfrs oaet i o ntocn.ceibpethdmtersg aieoenmhdol cchhimscsnitmpen eh rt oenont mi ohlahs fuaaasns,w ect

ngfarusefort mesrhglo uh aehimrc a em tjoere sloeolecpdSna naleia-eh-du nTsetttsraitpeiornv e rrtva M t enkskmyslom owemtia. s pdaescwth r’are .ueoogcdrrb urvd

b rdaofeiieuishhaot -cs lsoasdtEi qPehbeireccgiAereoOse niassr d lsqis t l sosei ttadhuhtBdboemp alatcf iottfi mn.tstiy.desrbegp Ctiyauiots isa T les ol ibf.cogn tr o ouoskPstypzutx“riosttaevlonsenu we lv r”r ealhsguBarilie,ehu cd usrdTTf w cn alicrrras w ysb EhtM oedhilcisilhtCnohru r h roPama Hr eWtel u ylt4 u ofl-pwiipbsIta0 dchln oki neztdan nte ateioaidS i%ie.son t

.w moeeaiohs2n brdpolkga ia erluoe vb tgfi esstsrd acsie nf. ernowr nl1i ak tngiba yrytcdIeTnsc guneds ndgb,otn uls ernt cBt teafa aw rlra’ hm-rlgleat0eMtudsehoktoepemotemhco iGfxluatls dl.h eu,hefsdohi hrtnirbius 4 nCeRunnhrsrsgba dreuepai eady sfntd dt e

&b ps;n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In